Phthalates: Biomarkers and human biomonitoring

Issues in Toxicology

Volumn 1, Issue , 2012, Pages 179-233

  Koch, Holger M ^a   Angerer, Jürgen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898753799     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: None     Document Type: Article

References (250)

1. EC. Risk assessment reports on phthalates. (http://ecb.jrc.it/home. php?CONTENU1/4/DOCUMENTS/Existing-Chemicals/RISK-ASSESS MENT/). 2008. European Commission. European Chemicals Bureau. 12-1-2008.
2. P. M. Lorz, F. K. Towae, W. Enke, R. Jackh, N. Bhargava, Phthalic acid and derivatives, In: Wiley-VCH (Ed.) (Ed.), Ullmann's Encyclopedia of Industrial Chemistry Release 2003, 7th Edition Online, Wiley-VCH, Weinheim, Germany, 2002.
3. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isononyl phthalate, Reprod. Toxicol., 2002, 16, 679-708.
4. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di (2-ethylhexyl) phthalate, Reprod. Toxicol., 2002, 16, 529-653.
5. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate, Reprod. Toxicol., 2002, 16, 489-527.
6. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of butyl benzyl phthalate, Reprod. Toxicol., 2002, 16, 453-487.
7. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-octyl phthalate, Reprod. Toxicol., 2002, 16, 721-734.
8. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-hexyl phthalate, Reprod. Toxicol., 2002, 16, 709-719.
9. R. Kavlock, K. Boekelheide, R. Chapin, M. Cunningham, E. Faustman, P. Foster, M. Golub, R. Henderson, I. Hinberg, R. Little, J. Seed, K. Shea, S. Tabacova, R. Tyl, P. Williams and T. Zacharewski, NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isodecyl phthalate, Reprod. Toxicol., 2002, 16, 655-678.
10. FDA. Safety Assessment of di (2-ethylhexyl) phthalate (DEHP) Released from PVC Medical Devices. (http://www.fda.gov/cdrh/ost/dehp-pvc.pdf). 2001. Rockville, MD, Center for Devices and Radiological Health, U. S. Food and Drug Administration. 11-8-2003.
11. ECB. European Union Risk Assessment Report for 1, 2-Benzenedicarboxylic Acid, Di-C8-10-Branched Alkyl Esters, C9-Rich and Di-"Isononyl" Phthalate (DINP) (Final Report 2003). 2003. Ispra, Italy, European Chemical Bureau.
12. ECB. European Union Risk Assessment Report for 1, 2-Benzenedicarboxylic Acid, Di-C9-11-Branched Alkyl Esters, C10-Rich and di-"isodecyl" Phthalate (DIDP) (Final Report). 2003. Ispra, Italy, European Chemicals Bureau.
13. ECB. European Union Risk Assessment Report for Dibutyl Phthalate (with addendum 2004). 2004. Ispra, Italy, European Chemicals Bureau.
14. ECB. European Union Risk Assessment Report for Benzyl Butyl Phthalate (Final Report 2007). 2007. Ispra, Italy, European Chemicals Bureau.
15. ECB. European Union Risk Assessment Report for Bis (2-ethylhexyl) phthalate (Final Report 2008). 2008. Ispra, Italy, European Chemicals Bureau.
16. R. Kavlock, D. Barr, K. Boekelheide, W. Breslin, P. Breysse, R. Chapin, K. Gaido, E. Hodgson, M. Marcus, K. Shea and P. Williams, NTPCERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di (2-ethylhexyl) phthalate, Reprod. Toxicol., 2006, 22, 291-399.
17. M. K. Stanley, K. A. Robillard, C. A. Staples, Q3 phthalate estersintroduction, In: Staples, C. A. (Ed.), The Handbook of Environmental Chemistry, Springer Verlag, New York, 2003, pp. 1-7.
18. R. Hauser, S. Duty, L. Godfrey-Bailey and A. M. Calafat, Medications as a source of human exposure to phthalates, Environ. Health Perspect., 2004, 112, 751-753.
19. H. M. Koch, J. Muller, H. Drexler and J. Angerer, Dibutylphthalate (DBP) in medications: are pregnant women and infants at risk? Umweltmed Forsch Prax, 2005, 10, 144-146.
20. B. O. Keller, A. G. Davidson and S. M. Innis, Phthalate metabolites in urine of CF patients are associated with use of enteric-coated pancreatic enzymes, Environ. Toxicol. Pharmacol., 2009, 27, 424-427.
21. E. Seckin, H. Fromme and W. Volkel, Determination of total and free mono-n-butyl phthalate in human urine samples after medication of a dinbutyl phthalate containing capsule, Toxicol. Lett., 2009, 188, 33-37.
22. Opinion on Phthalates in Cosmetic Products-adopted by the Scientific Committee on Consumer Products at its 11th plenary meeting of 21 March 2007. 2007. DG SANCO-European Commission, Health & Consumer Protection Directorate-General.
23. BfR. Di-isobutylphthalat in Papieren und Kartons für den Kontakt mit Lebensmitteln-Kurzprotokoll einer außerordentlichen Sitzung der Arbeitsgruppe "Papier, Karton und Pappe" vom 5. Juli 2007 im BfR. 2007. Bundesinstitut für Risikobewertung.
24. S. N. Bizzari, M. Blagoev and A. Kishi. Plasticizers. 2009. SRI Consulting. Chemical Economics Handbook Marketing Research Report.
25. M. European Council for Plasticizers and Intermediates-Saykali. Phthalates and their future in PVC applications-Current status and path forward. PVC Plasticizers 2010. 10-2-2010. 10-2-2010.
26. L. G. Parks, J. S. Ostby, C. R. Lambright, B. D. Abbott, G. R. Klinefelter, N. J. Barlow and L. E. Gray, Jr., The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat, Toxicol. Sci., 2000, 58, 339-349.
27. G. W. Wolfe and K. A. Layton. Multigeneration Reproduction Toxicity Study in Rats: Diethylhexylphthalate: Multigenerational reproductive assessment by continuous breeding when administered to Sprague-Dawley rats in the diet. TRC Study No 7244-200. 2003. TherImmune Research Corporation (Gaithersburg, Maryland).
28. L. E. Gray, J. Ostby, J. Furr, M. Price, D. N. Veeramachaneni and L. Parks, Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat, Toxicol. Sci., 2000, 58, 350-365.
29. A. J. Andrade, S. W. Grande, C. E. Talsness, C. Gericke, K. Grote, A. Golombiewski, A. Sterner-Kock and I. Chahoud, A dose response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult male offspring rats, Toxicology, 2006, 228, 85-97.
30. E. Mylchreest, D. G. Wallace, R. C. Cattley and P. M. D. Foster, Dosedependent alterations in androgen-regulated male reproductive development in rats exposed to di (n-butyl) phthalate during late gestation, Toxicol. Sci., 2000, 55, 143-151.
31. K. Y. Lee, M. Shibutani, H. Takagi, N. Kato, S. Takigami, C. Uneyama and M. Hirose, Diverse developmental toxicity of di-n-butyl phthalate in both sexes of rat offspring after maternal exposure during the period from late gestation through lactation, Toxicology, 2004, 203, 221-238.
32. J. Borch, M. Axelstad, A. M. Vinggaard and M. Dalgaard, Diisobutyl phthalate has comparable anti-androgenic effects to di-n-butyl phthalate in fetal rat testis, Toxicol. Lett., 2006, 163, 183-190.
33. A. M. Saillenfait, J. P. Sabate and F. Gallissot, Developmental toxic effects of diisobutyl phthalate, the methyl-branched analogue of di-n-butyl phthalate, administered by gavage to rats, Toxicol. Lett., 2006, 165, 39-46.
34. A. M. Saillenfait, J. P. Sabate and F. Gallissot, Diisobutyl phthalate impairs the androgen-dependent reproductive development of the male rat, Reproductive Toxicology, 2008, 26, 107-115.
35. T. Nagao, R. Ohta, H. Marumo, T. Shindo, S. Yoshimura and H. Ono, Effect of butyl benzyl phthalate in Sprague-Dawley rats after gavage administration: a two-generation reproductive study, Reprod. Toxicol., 2000, 14, 513-532.
36. R. W. Tyl, C. B. Myers, M. C. Marr, P. A. Fail, J. C. Seely, D. R. Brine, R. A. Barter and J. H. Butala, Reproductive toxicity evaluation of dietary butyl benzyl phthalate (BBP) in rats, Reprod. Toxicol., 2004, 18, 241-264.
37. P. M. Foster, J. R. Foster, M. W. Cook, L. V. Thomas and S. D. Gangolli, Changes in ultrastructure and cytochemical localization of zinc in rat testis following the administration of di-n-pentyl phthalate, Toxicol. Appl. Pharmacol., 1982, 63, 120-132.
38. K. L. Howdeshell, V. S. Wilson, J. Furr, C. R. Lambright, C. V. Rider, C. R. Blystone, A. K. Hotchkiss and L. E. Gray, A mixture of five phthalate esters inhibits fetal testicular testosterone production in the Sprague-Dawley rat in a cumulative, dose-additive manner, Toxicol. Sci., 2008, 105, 153-165.
39. J. Borch, O. Ladefoged, U. Hass and A. M. Vinggaard, Steroidogenesis in fetal male rats is reduced by DEHP and DINP, but endocrine effects of DEHP are not modulated by DEHA in fetal, prepubertal and adult male rats, Reprod. Toxicol., 2004, 18, 53-61.
40. R. M. Sharpe and D. S. Irvine, How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health?, Br. Med. J., 2004, 328, 447-451.
41. V. S. Wilson, C. Lambright, J. Furr, J. Ostby, C. Wood, G. Held and L. E. Gray, Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis, Toxicol. Lett., 2004, 146, 207-215.
42. P. M. D. Foster, Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters, Int. J. Androl., 2006, 29, 140-147.
43. L. E. Gray, J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni and L. Parks, Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat, Toxicol. Sci., 2000, 58, 350-365.
44. K. L. Howdeshell, C. V. Rider, V. S. Wilson and L. E. Gray, Mechanisms of action of phthalate esters, individually and in combination, to induce abnormal reproductive development in male laboratory rats, Environ. Res., 2008, 108, 168-176.
45. P. M. Foster, Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters, Int. J. Androl., 2006, 29, 140-147.
46. V. S. Wilson, C. R. Blystone, A. K. Hotchkiss, C. V. Rider and L. E. Gray, Jr., Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development, Int. J. Androl., 2008, 31, 178-187.
47. R. M. Sharpe and N. E. Skakkebaek, Male reproductive disorders and the role of endocrine disruption: Advances in understanding and identification of areas for future research, Pure App. Chem., 2003, 75, 2023-2038.
48. G. Lottrup, A. M. Andersson, H. Leffers, G. K. Mortensen, J. Toppari, N. E. Skakkebaek and K. M. Main, Possible impact of phthalates on infant reproductive health, Int. J. Androl., 2006, 29, 172-180.
49. L. E. Gray, N. J. Barlow, K. L. Howdeshell, J. S. Ostby, J. R. Furr and C. L. Gray, Transgenerational effects of Di (2-ethylhexyl) phthalate in the male CRL:CD (SD) rat: added value of assessing multiple offspring per litter, Toxicol. Sci., 2009, 110, 411-425.
50. N. E. Skakkebaek, Endocrine disrupters and testicular dysgenesis syndrome, Horm. Res., 2002, 57 Suppl 2, 43.
51. N. E. Skakkebaek, E. Rajpert-De Meyts and K. M. Main, Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects, Hum. Reprod., 2001, 16, 972-978.
52. R. M. Sharpe and N. E. Skakkebaek, Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects., Fertil. Steril., 2008, 89, e33-e38.
53. S. H. Swan, Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans, Environ. Res., 2008, 108, 177-184.
54. Committee on the Health Risks of Phthalates Phthalates and Cumulative Risk Assessment - The Task Ahead, The National Academies Press, Washington, 2008.
55. S. H. Swan, K. M. Main, F. Liu, S. L. Stewart, R. L. Kruse, A. M. Calafat, C. S. Mao, J. B. Redmon, C. L. Ternand, S. Sullivan and J. L. Teague, Decrease in anogenital distance among male infants with prenatal phthalate exposure, Environ. Health Perspect., 2005, 113, 1056-1061.
56. S. M. Duty, A. M. Calafat, M. J. Silva, L. Ryan and R. Hauser, Phthalate exposure and reproductive hormones in adult men, Hum. Reprod., 2005, 20, 604-610.
57. R. Hauser, J. D. Meeker, S. Duty, M. J. Silva and A. M. Calafat, Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites, Epidemiology, 2006, 17, 682-691.
58. S. M. Duty, A. M. Calafat, M. J. Silva, J. W. Brock, L. Ryan, Z. Chen, J. Overstreet and R. Hauser, The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters, J. Androl., 2004, 25, 293-302.
59. S. M. Duty, M. J. Silva, D. B. Barr, J. W. Brock, L. Ryan, Z. Y. Chen, R. F. Herrick, D. C. Christiani and R. Hauser, Phthalate exposure and human semen parameters, Epidemiology, 2003, 14, 269-277.
60. R. Hauser, J. D. Meeker, N. P. Singh, M. J. Silva, L. Ryan, S. Duty and A. M. Calafat, DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites, Hum. Reprod., 2007, 22, 688-695.
61. S. M. Duty, N. P. Singh, M. J. Silva, D. B. Barr, J. W. Brock, L. Ryan, R. F. Herrick, D. C. Christiani and R. Hauser, The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay, Environ. Health Perspect., 2003, 111, 1164-1169.
62. R. W. Stahlhut, E. Van Wijngaarden, T. D. Dye, S. Cook and S. H. Swan, Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult US males, Environ. Health Perspect., 2007, 115, 876-882.
63. E. E. Hatch, J. W. Nelson, M. M. Qureshi, J. Weinberg, L. L. Moore, M. Singer and T. F. Webster, Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a crosssectional study of NHANES data, 1999-2002, Environ. Health, 2008, 7, 27.
64. E. E. Hatch, J. W. Nelson, R. W. Stahlhut and T. F. Webster, Association of endocrine disruptors and obesity: perspectives from epidemiological studies, Int. J. Androl., 2010, 33, 324-332.
65. S. M. Engel, A. Miodovnik, R. L. Canfield, C. Zhu, M. J. Silva, A. M. Calafat and M. S. Wolff, Prenatal phthalate exposure is associated with childhood behavior and executive functioning, Environ. Health Perspect., 2010, 118, 565-571.
66. B. N. Kim, S. C. Cho, Y. Kim, M. S. Shin, H. J. Yoo, J. W. Kim, Y. H. Yang, H. W. Kim, S. Y. Bhang and Y. C. Hong, Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children, Biol. Psychiatry, 2009, 66, 958-963.
67. S. H. Swan, F. Liu, M. Hines, R. L. Kruse, C. Wang, J. B. Redmon, A. Sparks and B. Weiss, Prenatal phthalate exposure and reduced masculine play in boys, Int. J. Androl., 2010, 33, 259-269.
68. L. E. Gray, V. S. Wilson, T. Stoker, C. Lambright, J. Furr, N. Noriega, K. Howdeshell, G. T. Ankley and L. Guillette, Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals, Int. J. Androl., 2006, 29, 96-104.
69. C. V. Rider, J. Furr, V. S. Wilson and L. E. Gray, Jr., A mixture of seven antiandrogens induces reproductive malformations in rats, Int. J. Androl., 2008, 31, 249-262.
70. K. L. Howdeshell, J. Furr, C. R. Lambright, C. V. Rider, V. S. Wilson and L. E. Gray, Jr., Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: altered fetal steroid hormones and genes, Toxicol. Sci., 2007, 99, 190-202.
71. C. V. Rider, V. S. Wilson, K. L. Howdeshell, A. K. Hotchkiss, J. R. Furr, C. R. Lambright and L. E. Gray, Jr., Cumulative effects of in utero administration of mixtures of "antiandrogens" on male rat reproductive development, Toxicol. Pathol., 2009, 37, 100-113.
72. S. Christiansen, M. Scholze, M. Dalgaard, A. M. Vinggaard, M. Axelstad, A. Kortenkamp and U. Hass, Synergistic disruption of external male sex organ development by a mixture of four antiandrogens, Environ. Health Perspect., 2009, 117, 1839-1846.
73. A. Kortenkamp and M. Faust, Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment, Int. J. Androl., 2010, 33, 463-474.
74. C. V. Rider, J. R. Furr, V. S. Wilson and L. E. Gray, Jr., Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity, Int. J. Androl, 2010, 33, 443-462.
75. IRIS Toxicological Review and Summary Documents for Dibutyl Phthalate (External Peer Review). 2006. U. S. EPA.
76. EFSA. Statement of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission on the possibility of allocating a group-TDI for Butylbenzylphthalate (BBP), di-Butylphthalate (DBP), Bis (2-ethylhexyl) phthalate (DEHP), di-Isononylphthalate (DINP) and di-Isodecylphthalate (DIDP). 28-6-2005. European Food Safety Authority, Parma, Italy.
77. EFSA, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to di-butylphthalate (DBP) for use in food contact materials, The EFSA Journal, 2005, 242, 1-14.
78. EFSA, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to Bis (2-ethylhexyl) phthalate (DEHP) for use in food contact materials, The EFSA Journal, 2005, 243, 1-20.
79. EFSA, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to Di-isononylphthalate (DINP) for use in food contact materials, The EFSA Journal, 2005, 244, 77-83.
80. EFSA, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to Butylbenzylphthalate (BBP) for use in food contact materials, The EFSA Journal, 2005, 241, 1-14.
81. EFSA, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to Di-isodecylphthalate (DIDP) for use in food contact materials, The EFSA Journal, 2005, 245, 1-14.
82. European Union. Commission Directive 2004/93/EC of 21 September 2004 amending Council Directive 76/768/EEC for the purpose of adapting its Annexes II and III to technical progress. (http://ec.europa.eu/enterprise/cosmetics/doc/ 2004-93/en.pdf). 2004. Council, European Parliament. 12-1-2008.
83. European Union. Directive 2005/90/EC of the European Parliament and of the Council of 18 January 2006 amending, for the 29th time, Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (substances classified as carcinogenic, mutagenic or toxic to reproduction-c/m/r) Text with EEA relevance. (http://eur-lex.europa.eu/LexUriServ/LexUriServ. do?uri1/4OJ:L:2006:033:0028: 01:EN:HTML). 2006. Council, European Parliament. 12-1-2008.
84. M. Wittassek, H. M. Koch, J. Angerer and T. Brüning, Assessing exposure to phthalates-The human biomonitoring approach, Mol. Nutr. Food Res., 2010, 55, 7-31.
85. H. Fromme, L. Gruber, M. Schlummer, G. Wolz, S. Bohmer, J. Angerer, R. Mayer, B. Liebl and G. Bolte, Intake of phthalates and di (2-ethylhexyl) adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data, Environ. Int., 2007, 33, 1012-1020.
86. S. M. Duty, R. M. Ackerman, A. M. Calafat and R. Hauser, Personal care product use predicts urinary concentrations of some phthalate monoesters, Environ. Health Perspect., 2005, 113, 1530-1535.
87. J. J. Adibi, R. M. Whyatt, P. L. Williams, A. M. Calafat, D. Camann, R. Herrick, H. Nelson, H. K. Bhat, F. P. Perera, M. J. Silva and R. Hauser. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ. Health Perspect., 2008.
88. K. Becker, M. Seiwert, J. Angerer, W. Heger, H. M. Koch, R. Nagorka, E. Rosskamp, C. Schluter, B. Seifert and D. Ullrich, DEHP metabolites in urine of children and DEHP in house dust, Int. J. Hyg. Environ. Health, 2004, 207, 409-417.
89. Bundesinstitut für Risikobewertung. Übergang von Phthalaten aus Twist off-Deckeln in Lebensmittel-Aktualisierte Stellungnahme Nr. 025/2007. 2007. Berlin, Germany. Stellungnahme des Bundesinstitutes für Risikobewertung (BfR).
90. K. Clark, I. Cousins, D. MacKay, Assessment of critical exposure pathways, In: Staples, C. (Ed.), The Handbook of Environmental Chemistry, 3Q. Phthalate Esters, Springer, New York, 2003, pp. 227-262.
91. M. Wormuth, M. Scheringer, M. Vollenweider and K. Hungerbuhler, What are the sources of exposure to eight frequently used phthalic acid esters in Europeans?, Risk Analysis, 2006, 26, 803-824.
92. J. H. Peterson and T. Breindahl, Plasticizers in total diet samples, baby food and infant formulae, Food Additives and Contaminants, 2000, 17, 133-141.
93. MAFF. Survey of Plasticiser Levels in food Contact Materials and in Foods. Food Surveillance Papers No 21. 1996. Tertiary Survey of plasticiser levels in food contact materials and in foods. Food Surveillance Papers No 21.
94. MAFF. Phthalates in food-MAFF UK Food Surveillance Information Sheet No. 82. 1996. London, UK. Tertiary Phthalates in food-MAFF UK Food Surveillance Information Sheet No. 82.
95. MAFF. Phthalates in Infant Formulae-Follow-up Survey. MAFF UK Food Surveillance Information Sheet No. 168. 1998. London, UK. Tertiary Phthalates in Infant Formulae-Follow-up Survey. MAFF UK Food Surveillance Information Sheet No. 168.
96. A. K. Müller, E. Nielsen and O. Ladefoget. Human Exposure to Selected Phthalates in Denmark. 2003. Søborg, Denmark. Tertiary Human exposure to selected phthalates in Denmark.
97. M. E. Meek and P. K. L. Chan, Bis (2-Ethylhexyl) Phthalate-evaluation of risks to health from environmental exposure in Canada, J. Environ. Sci. Health, Part C: Environ. Carcinog. Ecotoxicol. Rev., 1994, 12, 179-194.
98. C. F. Wilkinson and J. C. Lamb, The potential health effects of phthalate esters in children's toys: a review and risk assessment, Regul. Toxicol. Pharmacol., 1999, 30, 140-155.
99. M. A. Babich, S. B. Chen, M. A. Greene, C. T. Kiss, W. K. Porter, T. P. Smith, M. L. Wind and W. W. Zamula, Risk assessment of oral exposure to diisononyl phthalate from children's products, Regul. Toxicol. Pharmacol., 2004, 40, 151-167.
100. K. M. Main, G. K. Mortensen, M. M. Kaleva, K. A. Boisen, I. N. Damgaard, M. Chellakooty, I. M. Schmidt, A. M. Suomi, H. E. Virtanen, J. H. Petersen, A. M. Andersson, J. Toppari and N. E. Skakkebaek, Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age, Environ. Health Perspect., 2006, 114, 270-276.
101. G. K. Mortensen, K. M. Main, A. M. Andersson, H. Leffers and N. E. Skakkebaek, Determination of phthalate monoesters in human milk, consumer milk, and infant formula by tandem mass spectrometry (LCMS-MS), Anal. Bioanal. Chem., 2005, 382, 1084-1092.
102. G. Latini, M. Wittassek, A. Del Vecchio, G. Presta, C. De Felice and J. Angerer, Lactational exposure to phthalates in Southern Italy, Environ. Int., 2009, 35, 236-239.
103. S. Hernandez-Diaz, A. A. Mitchell, K. E. Kelley, A. M. Calafat and R. Hauser, Medications as a potential source of exposure to phthalates in the US population, Environ. Health Perspect., 2009, 117, 185-189.
104. R. Hauser, S. Duty, L. Godfrey-Bailey and A. M. Calafat, Medications as a source of human exposure to phthalates, Environ. Health Perspect., 2004, 112, 751-753.
105. SCENIHR-Scientific Committee on Emerging and Newly-Identified Health Risks. Opinion on the safety of medical devices containing DEHP-plasticized PVC or other plasticizers on neonates andother groups possibly at risk. 6-2-2008. European Commission.
106. Health Canada. DEHP in Medical Devices: An exposure and toxicity assessment. 2002. Ottawa, Canada. Tertiary DEHP in Medical Devices: An exposure and toxicity assessment.
107. J. Weuve, B. N. Sanchez, A. M. Calafat, T. Schettler, R. A. Green, H. Hu and R. Hauser, Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites, Environ. Health Perspect., 2006, 114, 1424-1431.
108. A. M. Calafat, L. L. Needham, M. J. Silva and G. Lambert, Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit, Pediatrics, 2004, 113, e429-e434.
109. H. M. Koch, R. Preuss and J. Angerer, Di (2-ethylhexyl) phthalate (DEHP): human metabolism and internal exposure-an update and latest results, Int. J. Androl., 2006, 29, 155-165.
110. V. Weisbach, H. M. Koch, J. Angerer and R. Eckstein, Di (2-ethylhexyl) phthalate exposure of apheresis donors is procedure-related, Transfusion, 2006, 46, 1457-1458.
111. H. M. Koch, J. Angerer, H. Drexler, R. Eckstein and V. Weisbach, Di (2-ethylhexyl) phthalate (DEHP) exposure of voluntary plasma and platelet donors, Int. J. Hyg. Environ. Health, 2005, 208, 489-498.
112. H. M. Koch, H. M. Bolt, R. Preuss, R. Eckstein, V. Weisbach and J. Angerer, Intravenous exposure to di (2-ethylhexyl) phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation, Arch. Toxicol., 2005, 79, 689-693.
113. N. Monfort, R. Ventura, A. Latorre, V. Belalcazar, M. Lopez and J. Segura, Urinary di-(2-ethylhexyl) phthalate metabolites in athletes as screening measure for illicit blood doping: a comparison study with patients receiving blood transfusion, Transfusion, 2009.
114. H. M. Koch and A. M. Calafat, Human body burdens of chemicals used in plastic manufacture, Philos. Trans. R. Soc. Lond, B; Biol. Sci., 2009, 364, 2063-2078.
115. ECB, The European Union System for the Evaluation of Substances (EUSES). European Chemicals Bureau (ECB), 2007.
116. L. Attias, P. Boccardi, G. Boeije, D. Brooke, J. de Bruijn, M. Comber, B. Dolan, S. Fischer, G. Heinemeyer, V. Koch, J. Lijzen, B. Muller, R. Murray-Smith, M. Rikken, J. Tadeo and T. Vermeire, European union system for the evaluation of substances: the second version, Chemosphere, 2005, 59, 473-485.
117. Division of Environmental Health & Risk Management. Measuring the Bioavailability of Human Dietary Intake of PAH, Phthalates and Aromatic Hydrocarbons. Report prepared for the Food Standards Agency. 2003. London, UK. Tertiary Measuring the bioavailability of human dietary intake of PAH, phthalates and aromatic hydrocarbons. Report prepared for the Food Standards Agency.
118. M. Wormuth, E. Demou, M. Scheringer and K. Hungerbuhler, Assessments of direct human exposure: the approach of EU risk assessments compared to scenario-based risk assessment, Risk Anal., 2007, 27, 979-990.
119. E. J. Furtaw, Jr., An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory, Toxicol. Ind. Health, 2001, 17, 302-314.
120. R. Stiles, I. Yang, R. L. Lippincott, E. Murphy and B. Buckley, Potential sources of background contaminants in solid phase extraction and microextraction, J. Sep. Sci., 2007, 30, 1029-1036.
121. M. Abb, T. Heinrich, E. Sorkau and W. Lorenz, Phthalates in house dust, Environ. Int., 2009, 35, 965-970.
122. A. Fankhauser-Noti and K. Grob, Blank problems in trace analysis of diethylhexyl and dibutyl phthalate: investigation of the sources, tips and tricks, Anal. Chim. Acta, 2007, 582, 353-360.
123. P. G. Georgopoulos, A. F. Sasso, S. S. Isukapalli, P. J. Lioy, D. A. Vallero, M. Okino and L. Reiter, Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities, J. Expo. Sci. Environ. Epidemiol., 2009, 19, 149-171.
124. P. G. Georgopoulos, S. W. Wang, Y. C. Yang, J. Xue, V. G. Zartarian, T. McCurdy and H. Ozkaynak, Biologically based modeling of multimedia, multipathway, multiroute population exposures to arsenic, J. Expo. Sci. Environ. Epidemiol., 2008, 18, 462-476.
125. J. Angerer, U. Ewers and M. Wilhelm, Human biomonitoring: state of the art, Int. J. Hyg. Environ. Health, 2007, 210, 201-228.
126. J. Angerer, M. G. Bird, T. A. Burke, N. G. Doerrer, L. Needham, S. H. Robison, L. Sheldon and H. Zenick, Strategic biomonitoring initiatives: moving the science forward, Toxicol. Sci., 2006, 93, 3-10.
127. L. L. Needham, A. M. Calafat and D. B. Barr, Assessing developmental toxicant exposures via biomonitoring, Basic Clin. Pharmacol. Toxicol., 2008, 102, 100-108.
128. L. L. Needham, A. M. Calafat and D. B. Barr, Uses and issues of biomonitoring, Int. J. Hyg. Environ. Health, 2007, 210, 229-238.
129. L. L. Needham and K. Sexton, Assessing children's exposure to hazardous environmental chemicals: an overview of selected research challenges and complexities., J. Expos. Anal. Environ. Epidemiol., 2000, 10, 611-629.
130. C. E. Cowan-Ellsberry and S. H. Robison, Refining aggregate exposure: Example using parabens, Regul. Toxicol. Pharmacol., 2009.
131. W. Kessler, W. Phokha, G. A. Csanady and J. G. Filser, No background concentrations of di (2-ethylhexyl) phthalate and mono (2-ethylhexyl) phthalate in blood of rats, Arch. Toxicol., 2001, 75, 62-64.
132. W. Kessler, W. Numtip, K. Grote, G. A. Csanady, I. Chahoud and J. G. Filser, Blood burden of di (2-ethylhexyl) phthalate and its primary metabolite mono (2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets, Toxicol. Appl. Pharmacol., 2004, 195, 142-153.
133. H. M. Koch, H. M. Bolt and J. Angerer, Di (2-ethylhexyl) phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP, Arch. Toxicol., 2004, 78, 123-130.
134. P. W. Albro and B. Moore, Identification of the metabolites of simple phthalate diesters in rat urine, J. Chromatogr., 1974, 94, 209-218.
135. ATSDR. Toxicological Profile for Diethyl phthalate (DEP). (http://www.atsdr.cdc.gov/toxprofiles/tp73.html). 1995. Atlanta, GA, Agency for Toxic Substances and Disease Registry. 26-7-2004.
136. ATSDR. Toxicological Profile for Di-n-butyl phthalate (DBP). (http://www.atsdr.cdc.gov/toxprofiles/tp135.html). 2001. Atlanta, GA, Agency for Toxic Substances and Disease Registry. 26-7-2004.
137. W. A. C. Anderson, L. Castle, M. J. Scotter, R. C. Massey and C. Springall, A biomarker approach to measuring human dietary exposure to certain phthalate diesters, Food Addit. Contam., 2001, 18, 1068-1074.
138. P. W. Albro and R. O. Thomas, Enzymatic hydrolysis of di-(2-ethylhexyl) phthalate by lipases, Biochim. Biophys. Acta, 1973, 306, 380-390.
139. P. W. Albro and S. R. Lavenhar, Metabolism of di (2-ethylhexyl) phthalate, Drug Metabol. Rev., 1989, 21, 13-34.
140. ATSDR. Toxicological Profile for Di-n-octyl phthalate (DNOP). (http://www.atsdr.cdc.gov/toxprofiles/tp95.html). 1997. Atlanta, GA, Agency for Toxic Substances and Disease Registry. 26-7-2004.
141. ATSDR. Toxicological Profile for Di (2-ethylhexyl) phthalate (DEHP). (http://www.atsdr.cdc.gov/toxprofiles/tp9.html). 2002. Atlanta, GA, Agency for Toxic Substances and Disease Registry. 26-7-2004.
142. K. Kato, M. J. Silva, C. Wolf, L. E. Gray, L. L. Needham and A. M. Calafat, Urinary metabolites of diisodecyl phthalate in rats, Toxicology, 2007, 236, 114-122.
143. H. M. Koch, H. M. Bolt, R. Preuss and J. Angerer, New metabolites of di (2-ethylhexyl) phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP, Arch. Toxicol., 2005, 79, 367-376.
144. H. M. Koch and J. Angerer, Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP, Int. J. Hyg. Environ. Health, 2007, 210, 9-19.
145. M. J. Silva, K. Kato, C. Wolf, E. Samandar, S. S. Silva, E. L. Gray, L. L. Needham and A. M. Calafat, Urinary biomarkers of di-isononyl phthalate in rats, Toxicology, 2006, 223, 101-112.
146. M. J. Silva, E. Samandar, J. A. Reidy, R. Hauser, L. L. Needham and A. M. Calafat, Metabolite profiles of di-n-butyl phthalate in humans and rats, Environ. Sci. Technol., 2007, 41, 7576-7580.
147. H. M. Koch and J. Angerer, Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP, Int. J. Hyg. Environ. Health, 2007, 210, 9-19.
148. H. M. Koch, H. M. Bolt, R. Preuss and J. Angerer, New metabolites of di
149. H. M. Koch, H. M. Bolt and J. Angerer, Di (2-ethylhexyl) phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP, Arch. Toxicol., 2004, 78, 123-130.
150. M. J. Silva, J. A. Reidy, K. Kato, J. L. Preau, Jr., L. L. Needham and A. M. Calafat, Assessment of human exposure to di-isodecyl phthalate using oxidative metabolites as biomarkers, Biomarkers, 2007, 12, 133-144.
151. M. J. Silva, J. A. Reidy, J. L. Preau, Jr., L. L. Needham and A. M. Calafat, Oxidative metabolites of diisononyl phthalate as biomarkers for human exposure assessment, Environ. Health Perspect., 2006, 114, 1158-1161.
152. M. J. Silva, J. A. Reidy, J. L. Preau, E. Samandar, L. L. Needham and A. M. Calafat, Measurement of eight urinary metabolites of di (2-ethylhexyl) phthalate as biomarkers for human exposure assessment, Biomarkers, 2006, 11, 1-13.
153. M. J. Silva, E. Samandar, J. L. Preau, Jr., L. L. Needham and A. M. Calafat, Urinary oxidative metabolites of di (2-ethylhexyl) phthalate in humans, Toxicology, 2006, 219, 22-32.
154. M. Wittassek and J. Angerer, Phthalates: metabolism and exposure, Int. J. Androl., 2008, 31, 131-138.
155. M. J. Silva, J. A. Reidy, K. Kato, J. L. Preau, L. L. Needham and A. M. Calafat, Assessment of human exposure to di-isodecyl phthalate using oxidative metabolites as biomarkers, Biomarkers, 2007, 12, 133-144.
156. B. C. Blount, M. J. Silva, S. P. Caudill, L. L. Needham, J. L. Pirkle, E. J. Sampson, G. W. Lucier, R. J. Jackson and J. W. Brock, Levels of seven urinary phthalate metabolites in a human reference population, Environ. Health Perspect., 2000, 108, 979-982.
157. R. Preuss, H. M. Koch and J. Angerer, Biological monitoring of the five major metabolites of di-(2-ethylhexyl) phthalate (DEHP) in human urine using column-switching liquid chromatography-tandem mass spectrometry, J. Chromatogr. B, 2005, 816, 269-280.
158. A. M. Calafat, A. R. Slakman, M. J. Silva, A. R. Herbert and L. L. Needham, Automated solid phase extraction and quantitative analysis of human milk for 13 phthalate metabolites, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 805, 49-56.
159. K. Kato, M. J. Silva, L. L. Needham and A. M. Calafat, Quantifying phthalate metabolites in human meconium and semen using automated off-line solid-phase extraction coupled with on-line SPE and isotopedilution high-performance liquid chromatography-tandem mass spectrometry, Anal. Chem., 2006, 78, 6651-6655.
160. K. Kato, M. J. Silva, J. W. Brock, J. A. Reidy, N. A. Malek, C. C. Hodge, H. Nakazawa, L. L. Needham and D. B. Barr, Quantitative detection of nine phthalate metabolites in human serum using reversed-phase highperformance liquid chromatography-electrospray ionization-tandem mass Spectrometry, J. Anal. Toxicol., 2003, 27, 284-289.
161. M. Wittassek, J. Angerer, M. Kolossa-Gehring, S. D. Schafer, W. Klockenbusch, L. Dobler, A. K. Gunsel, A. Muller and G. A. Wiesmuller, Fetal exposure to phthalates - hyphen;a pilot study, Int. J. Hyg. Environ. Health, 2009, 212, 492-498.
162. H. M. Koch, B. Rossbach, H. Drexler and J. Angerer, Internal exposure of the general population to DEHP and other phthalates - determination of secondary and primary phthalate monoester metabolites in urine, Environ. Res., 2003, 93, 177-185.
163. CDC. Third National Report on Human Exposure to Environmental Chemicals. (http://www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf). 2005. Atlanta, GA, Centers for Disease Control and Prevention; National Center for Environmental Health; Division of Laboratory Sciences. 11-4-2007.
164. M. Wittassek, G. A. Wiesmuller, H. M. Koch, R. Eckard, L. Dobler, J. Muller, J. Angerer and C. Schluter, Internal phthalate exposure over the last two decades - a retrospective human biomonitoring study, Int. J. Hyg. Environ. Health, 2007, 210, 319-333.
165. D. B. Barr, M. J. Silva, K. Kato, J. A. Reidy, N. A. Malek, D. Hurtz, M. Sadowski, L. L. Needham and A. M. Calafat, Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers, Environ. Health Perspect., 2003, 111, 1148-1151.
166. K. Kato, M. J. Silva, J. A. Reidy, D. Hurtz, III, N. A. Malek, L. L. Needham, H. Nakazawa, D. B. Barr and A. M. Calafat, Mono (2-ethyl-5- hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate, Environ. Health Perspect., 2004, 112, 327-330.
167. W. A. C. Anderson, L. Castle, M. J. Scotter, R. C. Massey and C. Springall, A biomarker approach to measuring human dietary exposure to certain phthalate diesters, Food Addit. Contam., 2001, 18, 1068-1074.
168. A. M. Calafat, M. J. Silva, J. A. Reidy, L. E. Gray, E. Samandar, J. L. Preau, A. R. Herbert and L. L. Needham, Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate, J. Toxicol. Environ. Health A, 2006, 69, 215-227.
169. M. J. Silva, K. Kato, E. L. Gray, C. Wolf, L. L. Needham and A. M. Calafat, Urinary metabolites of di-n-octyl phthalate in rats, Toxicology, 2005, 210, 123-133.
170. M. J. Silva, A. Reidy, J. L. Preau, E. Samandar, L. L. Needham and A. M. Calafat, Measurement of eight urinary metabolites of di (2-ethylhexyl) phthalate as biomarkers for human exposure assessment, Biomarkers, 2006, 11, 1-13.
171. L. L. Needham, D. G. Patterson, D. B. Barr, J. Grainger and A. M. Calafat, Uses of speciation techniques in biomonitoring for assessing human exposure to organic environmental chemicals, Anal. Bioanal. Chem., 2005, 381, 397-404.
172. D. B. Barr, R. Y. Wang and L. L. Needham, Biologic monitoring of exposure to environmental chemicals throughout the life stages: Requirements and issues for consideration for the National Children's Study, Environ. Health Perspect., 2005, 113, 1083-1091.
173. L. L. Needham, H. Ozkaynak, R. M. Whyatt, D. B. Barr, R. Y. Wang, L. Naeher, G. Akland, T. Bahadori, A. Bradman, R. Fortmann, L. J. S. Liu, M. Morandi, M. K. O'Rourke, K. Thomas, J. Quackenboss, P. B. Ryan and V. Zartarian, Exposure assessment in the National Children's Study: Introduction, Environ. Health Perspect., 2005, 113, 1076-1082.
174. S. Pichini, M. Pellegrini, R. Pacifici, E. Marchei, J. Murillo, C. Puig, O. Vall and O. Garcia-Algar, Quantification of arecoline (Areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/ electrospray quadrupole mass spectrometry, Rapid Commun. Mass Spectrom., 2003, 17, 1958-1964.
175. S. Pichini, R. Pacifici, M. Pellegrini, E. Marchei, J. Lozano, J. Murillo, O. Vall and O. Garcia-Algar, Development and validation of a highperformance liquid chromatography-Mass spectrometry assay for determination of amphetamine, methamphetamine, and methylenedioxy derivatives in meconium, Anal. Chem., 2004, 76, 2124-2132.
176. R. M. Whyatt and D. B. Barr, Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: A validation study, Environ. Health Perspect., 2001, 109, 417-420.
177. P. Kintz and N. Samyn, Use of alternative specimens: Drugs of abuse in saliva and doping agents in hair, Therapeutic Drug Monitoring, 2002, 24, 239-246.
178. A. Palmeri, S. Pichini, R. Pacifici, P. Zuccaro and A. Lopez, Drugs in nails-Physiology, pharmacokinetics and forensic toxicology, Clin. Pharm., 2000, 38, 95-110.
179. J. Angerer, U. Ewers and M. Wilhelm, Human biomonitoring: State of the art, Int. J. Hyg. Environ. Health, 2007, 210, 201-228.
180. C. Schulz, J. Angerer, U. Ewers and M. Kolossa-Gehring, The German Human Biomonitoring Commission, Int. J. Hyg. Environ. Health, 2007, 210, 373-382.
181. A. M. Calafat, A. R. Slakman, M. J. Silva, A. R. Herbert and L. L. Needham, Automated solid phase extraction and quantitative analysis of human milk for 13 phthalate metabolites, J. Chromatogr. B, 2004, 805, 49-56.
182. K. Kato, M. J. Silva, L. L. Needham and A. M. Calafat, Quantifying phthalate metabolites in human meconium and semen using automated off-line solid-phase extraction coupled with on-line SPE and isotopedilution high-performance liquid chromatography-tandem mass spectrometry, Anal. Chem., 2006, 78, 6651-6655.
183. T. Mose, G. K. Mortensen, M. Hedegaard and L. E. Knudsen, Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood, Reprod. Toxicol., 2007, 23, 83-91.
184. D. B. Barr, L. C. Wilder, S. P. Caudill, A. J. Gonzalez, L. L. Needham and J. L. Pirkle, Urinary creatinine concentrations in the U. S. population: implications for urinary biologic monitoring measurements, Environ. Health Perspect., 2005, 113, 192-200.
185. M. J. Silva, D. B. Barr, J. A. Reidy, N. A. Malek, C. C. Hodge, S. P. Caudill, J. W. Brock, L. L. Needham and A. M. Calafat, Urinary levels of seven phthalate metabolites in the US population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000, Environ. Health Perspect., 2004, 112, 331-338.
186. M. Lorber, J. Angerer and H. M. Koch, A simple pharmacokinetic model to characterize exposure of Americans to Di-2-ethylhexyl phthalate, J. Expo. Sci. Environ. Epidemiol., 2010, 20, 38-53.
187. H. M. Koch, K. Becker, M. Wittassek, M. Seiwert, J. Angerer and M. Kolossa-Gehring, Di-n-butylphthalate and butylbenzylphthalate-urinary metabolite levels and estimated daily intakes: pilot study for the German Environmental Survey on children, J. Exp. Sci. Envirom. Epidemiol., 2007, 17, 378-387.
188. H. M. Koch, H. Drexler and J. Angerer, Internal exposure of nurseryschool children and their parents and teachers to di (2-ethylhexyl) phthalate (DEHP), Int. J. Hyg. Environ. Health, 2004, 207, 15-22.
189. M. Wittassek, W. Heger, H. M. Koch, K. Becker, J. Angerer and M. Kolossa-Gehring, Daily intake of di (2-ethylhexyl) phthalate (DEHP) by German children-Acomparison of two estimationmodels based on urinary DEHP metabolite levels, Int. J. Hyg. Environ. Health, 2007, 210, 35-42.
190. T. Remer, A. Neubert and C. Maser-Gluth, Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research, Am. J. Clin. Nutr., 2002, 75, 561-569.
191. L. L. Needham, D. B. Barr and A. M. Calafat, Characterizing children's exposures: beyond NHANES, Neurotoxicology, 2005, 26, 547-553.
192. M. J. Silva, D. B. Barr, J. A. Reidy, N. A. Malek, C. C. Hodge, S. P. Caudill, J. W. Brock, L. L. Needham and A. M. Calafat, Urinary levels of seven phthalate metabolites in the U. S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000, Environ. Health Perspect., 2004, 112, 331-338.
193. CDC. National Health and Nutrition Examination Survey. National Center for Health Statistics. (http://www.cdc.gov/nchs/nhanes.htm). 2003. 11-8-2003.
194. H. M. Koch, H. Drexler and J. Angerer, Response to the letter of R. M. David Int. J. Hyg. Environ. Health 207, 75-76 (2004)
195. Int. J. Hyg. Environ. Health, 2004, 207, 77-78.
196. A. M. Calafat and R. H. McKee, Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di (2-ethylhexyl) phthalate] as a case study, Environ. Health Perspect., 2006, 114, 1783-1789.
197. H. Fromme, G. Bolte, H. M. Koch, J. Angerer, S. Boehmer, H. Drexler, R. Mayer and B. Liebl, Occurrence and daily variation of phthalate metabolites in the urine of an adult population, Int. J. Hyg. Environ. Health, 2007, 210, 21-33.
198. H. Itoh, K. Yoshida and S. Masunaga, Quantitative identification of unknown exposure pathways of phthalates based on measuring their metabolites in human urine, Environ. Sci. Technol., 2007, 41, 4542-4547.
199. B. A. G. Jonsson, J. Richthoff, L. Rylander, A. Giwercman and L. Hagmar, Urinary phthalate metabolites and biomarkers of reproductive function in young men, Epidemiology, 2005, 16, 487-493.
200. J. A. Hoppin, J. W. Brock, B. J. Davis and D. D. Baird, Reproducibility of urinary phthalate metabolites in first morning urine samples, Environ. Health Perspect., 2002, 110, 515-518.
201. R. Hauser, J. D. Meeker, S. Park, M. J. Silva and A. M. Calafat, Temporal variability of urinary phthalate metabolite levels in men of reproductive age, Environ. Health Perspect., 2004, 112, 1734-1740.
202. J. L. Preau, Jr., L. Y. Wong, M. J. Silva, L. L. Needham and A. M. Calafat, Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di (2-ethylhexyl) phthalate among eight adults: an observational study, Environ. Health Perspect., 2010, 118, 1748-1754.
203. R. M. David, Exposure to phthalate esters, Environ. Health Perspect., 2000, 108, A440.
204. H. M. Koch, H. Drexler and J. Angerer, An estimation of the daily intake of di (2-ethylhexyl) phthalate (DEHP) and other phthalates in the general population, Int. J. Hyg. Environ. Health, 2003, 206, 1-7.
205. H. M. Koch, K. Becker, M. Wittassek, M. Seiwert, J. Angerer and M. Kolossa-Gehring, Di-n-butylphthalate and butylbenzylphthalate-urinary metabolite levels and estimated daily intakes: pilot study for the German Environmental Survey on children, J. Exp. Sci. Envirom. Epidemiol., 2007, 17, 378-387.
206. M. C. Kohn, F. Parham, S. A. Masten, C. J. Portier, M. D. Shelby, J. W. Brock and L. L. Needham, Human exposure estimates for phthalates, Environ. Health Perspect., 2000, 108, A440-A442.
207. M. Wittassek and J. Angerer. Phthalates: metabolism and exposure. Int. J. Androl., 2007.
208. M. Wittassek, W. Heger, H. M. Koch, K. Becker, J. Angerer and M. Kolossa-Gehring, Daily intake of di (2-ethylhexyl) phthalate (DEHP) by German children-A comparison of two estimation models based on urinary DEHP metabolite levels, Int. J. Hyg. Environ. Health, 2007, 210, 35-42.
209. M. C. Kohn, F. Parham, S. A. Masten, C. J. Portier, M. D. Shelby, J. W. Brock and L. L. Needham, Human exposure estimates for phthalates, Environ. Health Perspect., 2000, 108, A440-A442.
210. H. Itoh, K. Yoshida and S. Masunaga, Evaluation of the effect of governmental control of human exposure to two phthalates in Japan using a urinary biomarker approach, Int. J. Hyg. Environ. Health, 2005, 208, 237-245.
211. H. M. Koch, H. Drexler and J. Angerer, An estimation of the daily intake of di (2-ethylhexyl) phthalate (DEHP) and other phthalates in the general population, Int. J. Hyg. Environ. Health, 2003, 206, 77-83.
212. K. Marsee, T. J. Woodruff, D. A. Axelrad, A. M. Calafat and S. H. Swan, Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance, Environ. Health Perspect., 2006, 114, 805-809.
213. Wissenschaftliche Tabellen Geigy-Teilband Körperflüssigkeiten, Basel, 1977.
214. H. M. Koch, H. Drexler and J. Angerer, Letter to the editor, Reproductive Toxicology, 2004, 18, 759-760.
215. M. J. Silva, K. Kato, C. Wolf, E. Samandar, S. S. Silva, E. L. Gray, L. L. Needham and A. M. Calafat, Urinary biomarkers of di-isononyl phthalate in rats, Toxicology, 2006, 223, 101-112.
216. Y. Suzuki, M. Niwa, J. Yoshinaga, C. Watanabe, Y. Mizumoto, S. Serizawa and H. Shiraishi, Exposure assessment of phthalate esters in Japanese pregnant women by using urinary metabolite analysis, Environ. Health Prev. Med., 2009, 14, 180-187.
217. H. M. Koch, J. Angerer, H. Drexler, R. Eckstein and V. Weisbach, Di (2-ethylhexyl) phthalate (DEHP) exposure of voluntary plasma and platelet donors, Int. J. Hyg. Environ. Health, 2005, 208, 489-498.
218. V. Weisbach, H. M. Koch, J. Angerer and R. Eckstein, Di (2-ethylhexyl) phthalate exposure of apheresis donors is procedure-related, Transfusion, 2006, 46, 1457-1458.
219. A. M. Calafat, L. L. Needham, M. J. Silva and G. Lambert, Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit, Pediatrics, 2004, 113, e429-e434.
220. R. Green, R. Hauser, A. M. Calafat, J. Weuve, T. Schettler, S. Ringer, K. Huttner and H. HU, Use of di (2-ethylhexyl) phthalate-containing medical products and urinary levels of mono (2-ethylhexyl) phthalate in neonatal intensive care unit infants, Environ. Health Perspect., 2005, 113, 1222-1225.
221. J. Weuve, B. N. Sanchez, A. M. Calafat, T. Schettler, R. A. Green, H. HU and R. Hauser, Exposure to phthalates in neonatal intensive care unit infants: Urinary concentrations of monoesters and oxidative metabolites, Environ. Health Perspect., 2006, 114, 1424-1431.
222. D. Helm, Correlation between production amounts of DEHP and daily intake, Sci. Tot. Environ., 2007, 388, 389-391.
223. EPA. Integrated Risk Information System (IRIS). Dibutyl phthalate (CASRN 84-74-2). (http://www.epa.gov/ncea/iris/subst/0038.htm). 1990. U. S. Environmental Protection Agency. 12-1-2008.
224. EPA. Integrated Risk Information System (IRIS). Di (2-ethylhexyl) phthalate (DEHP) (CASRN 117-81-7). (http://www.epa.gov/IRIS/subst/0014.htm). 1993. U. S. Environmental Protection Agency. 12-1-2008.
225. EPA. Integrated Risk Information System (IRIS). Butyl benzyl phthalate (CASRN 85-68-7). (http://www.epa.gov/ncea/iris/subst/0293.htm). 1993. U. S. Environmental Protection Agency. 12-1-2008.
226. EPA. Integrated Risk Information System (IRIS). Diethyl phthalate (CASRN 84-66-2). (http://www.epa.gov/iris/subst/0226.htm). 1993. U. S. Environmental Protection Agency. 12-1-2008.
227. C. P. Carpenter, C. S. Weil and H. F. Smyth, Chronic oral toxicity of di (2-ethylhexyl) phthalate for rats, guinea pigs, and dogs, Ama Archives of Industrial Hygiene and Occupational Medicine, 1953, 8, 219-226.
228. C. C. Smith, Toxicity of butyl sterate, dibutyl sebacate, dibutyl phthalate and methoxyethyl oleate, Arch. Hyg. Occup. Med., 1953, 7, 310-318.
229. H. M. Koch, J. Müller, H. Drexler and J. Angerer, Dibutylphthalat (DBP) in Arzneimitteln: ein bisher unterschätztes Risiko für Schwangere und Kleinkinder, Umweltmed Forsch Prax, 2004, 10, 144-146.
230. H. M. Koch, H. Drexler and J. Angerer. DBP (Di-n-butylphthalate) in pharmaceuticals: are pregnant women and infants at risk? 15th Annual Conference of the International Society of Exposure Analysis. 2005. Tucson, Arizona, USA.
231. C. Buchta, C. Bittner, P. Hocker, M. Macher, R. Schmid, C. Seger and M. Dettke, Donor exposure to the plasticizer di (2-ethylhexyl) phthalate during plateletpheresis, Transfusion, 2003, 43, 1115-1120.
232. S. L. Plonait, H. Nau, R. F. Maier, W. Wittfoht and M. Obladen, Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters, Transfusion, 1993, 33, 598-605.
233. U. S. EPA. Framework for Cumulative Risk Assessment. PA/630/P-02/001A. U. S. Environmental Protection Agency, Risk Assessment Forum Office of Research and Development. 2003. Washington, DC.
234. R. M. Sharpe, "Additional" effects of phthalate mixtures on fetal testosterone production, Toxicol. Sci., 2008, 105, 1-4.
235. A. Kortenkamp, Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology, Int. J. Androl., 2008, 31, 233-240.
236. L. E. Gray, J. Ostby, J. Furr, M. Price, D. N. R. Veeramachaneni and L. Parks, Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat, Toxicol. Sci., 2000, 58, 350-365.
237. L. E. Gray, J. Furr, K. Howdeshell, A. Hotchkiss, V. Wilson and C. Rider, Cumulative effects of in utero administration of mixtures of "antiandrogens" on male rat reproductive development, Toxicology, 2007, 240, 139-140.
238. A. K. Hotchkiss, L. G. Parks-Saldutti, J. S. Ostby, C. Lambright, J. Furr, J. G. Vandenbergh and L. E. Gray, Jr., A mixture of the "antiandrogens" linuron and butyl benzyl phthalate alters sexual differentiation of the male rat in a cumulative fashion, Biol. Reprod., 2004, 71, 1852-1861.
239. C. M. Carruthers and P. M. D. Foster, Critical window of male reproductive tract development in rats following gestational exposure to di-nbutyl phthalate, Birth Defects Res. B-Dev. Reprod. Toxicol., 2005, 74, 277-285.
240. A. K. Hotchkiss, L. G. Parks-Saldutti, J. S. Ostby, C. Lambright, J. Furr, J. G. Vandenbergh and L. E. Gray, A mixture of the " antiandrogens" linuron and butyl benzyl phthalate alters sexual differentiation of the male rat in a cumulative fashion, Biol. Reprod., 2004, 71, 1852-1861.
241. K. L. Howdeshell, J. Furr, C. R. Lambright, C. V. Rider, V. S. Wilson and L. E. Gray, Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: Altered fetal steroid hormones and genes, Toxicol. Sci., 2007, 99, 190-202.
242. C. V. Rider, J. Furr, V. S. Wilson and L. E. Gray. A mixture of seven antiandrogens induces reproductive malformations in rats. Int. J. Androl., 2008.
243. P. Schmid and C. Schlatter, Excretion and metabolism of di (2-ethylhexyl) - phthalate in man, Xenobiotica, 1985, 15, 251-256.
244. J. W. Brock, S. P. Caudill, M. J. Silva, L. L. Needham and E. D. Hilborn, Phthalate monoesters levels in the urine of young children, Bull. Environ. Contam. Toxicol., 2002, 68, 309-314.
245. J. J. Adibi, R. Hauser, P. L. Williams, R. M. Whyatt, A. M. Calafat, H. Nelson, R. Herrick and S. H. Swan, Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study, Am. J. Epidemiol., 2009, 169, 1015-1024.
246. CDC. Fourth National Report on Human Exposure to Environmental Chemicals. 2009. Atlanta, GA, Centers for Disease Control and Prevention; National Center for Environmental Health; Division of Laboratory Sciences.
247. K. Becker, T. Goen, M. Seiwert, A. Conrad, H. Pick-Fuss, J. Muller, M. Wittassek, C. Schulz and M. Kolossa-Gehring, GerES IV: phthalate metabolites and bisphenol A in urine of German children, Int. J. Hyg. Environ. Health, 2009, 212, 685-692.
248. T. Berman, D. Hochner-Celnikier, A. M. Calafat, L. L. Needham, Y. Amitai, U. Wormser and E. Richter, Phthalate exposure among pregnant women in Jerusalem, Israel: Results of a pilot study, Environ. Int., 2009, 35, 353-357.
249. X. Ye, F. H. Pierik, R. Hauser, S. Duty, J. Angerer, M. M. Park, A. Burdorf, A. Hofman, V. W. Jaddoe, J. P. Mackenbach, E. A. Steegers, H. Tiemeier and M. P. Longnecker, Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study, Environ. Res., 2008, 108, 260-267.
250. P. C. Huang, P. L. Kuo, Y. L. Guo, P. C. Liao and C. C. Lee, Associations between urinary phthalate monoesters and thyroid hormones in pregnant women, Hum. Reprod., 2007, 22, 2715-2722.